AU Patent

AU2009335943A1 — Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis

Assigned to Medicis Pharmaceutical Corp · Expires 2013-10-24 · 13y expired

What this patent protects

Pharmaceutical formulations and methods for the topical or transdermal delivery of 1-isobutyl-1

USPTO Abstract

Pharmaceutical formulations and methods for the topical or transdermal delivery of 1-isobutyl-1

Drugs covered by this patent

Patent Metadata

Patent number
AU2009335943A1
Jurisdiction
AU
Classification
—
Expires
2013-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Medicis Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.